![]()
Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | (+)-schisandrin B | multiple interactions | ISO | RGD:620261 | 6480464 | schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of DYNLT1 mRNA] | CTD | PMID:31150632 | (-)-epigallocatechin 3-gallate | decreases expression | EXP | | 6480464 | epigallocatechin gallate results in decreased expression of DYNLT1 mRNA | CTD | PMID:22079256 | (-)-epigallocatechin 3-gallate | multiple interactions | EXP | | 6480464 | [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of DYNLT1 mRNA | CTD | PMID:22079256 | 1,2-dimethylhydrazine | decreases expression | ISO | RGD:732245 | 6480464 | 1, 2-Dimethylhydrazine results in decreased expression of DYNLT1B mRNA | CTD | PMID:22206623 | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of DYNLT1 mRNA | CTD | PMID:20106945, PMID:21632981 | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | RGD:620261 | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of DYNLT1 mRNA | CTD | PMID:34747641 | 2,4-dinitrotoluene | affects expression | ISO | RGD:620261 | 6480464 | 2, 4-dinitrotoluene affects the expression of TCTEX1 mRNA | CTD | PMID:21346803 | 3,3',5,5'-tetrabromobisphenol A | decreases expression | ISO | RGD:732245 | 6480464 | tetrabromobisphenol A results in decreased expression of DYNLT1B mRNA | CTD | PMID:25172293 | 4-hydroxyphenyl retinamide | increases expression | ISO | RGD:732245 | 6480464 | Fenretinide results in increased expression of DYNLT1 mRNA | CTD | PMID:28973697 | 6-propyl-2-thiouracil | increases expression | ISO | RGD:620261 | 6480464 | Propylthiouracil results in increased expression of DYNLT1 mRNA | CTD | PMID:24780913 | acetamide | increases expression | ISO | RGD:620261 | 6480464 | acetamide results in increased expression of DYNLT1 mRNA | CTD | PMID:31881176 | aflatoxin B1 | increases expression | ISO | RGD:620261 | 6480464 | Aflatoxin B1 results in increased expression of DYNLT1 mRNA | CTD | PMID:23630614, PMID:25378103 | all-trans-retinoic acid | increases expression | EXP | | 6480464 | Tretinoin results in increased expression of DYNLT1 mRNA | CTD | PMID:33167477 | ammonium chloride | affects expression | ISO | RGD:620261 | 6480464 | Ammonium Chloride affects the expression of DYNLT1 mRNA | CTD | PMID:16483693 | amphetamine | increases expression | ISO | RGD:620261 | 6480464 | Amphetamine results in increased expression of DYNLT1 mRNA | CTD | PMID:30779732 | auramine O | increases expression | EXP | | 6480464 | Benzophenoneidum results in increased expression of DYNLT1 protein | CTD | PMID:28722353 | benzo[a]pyrene | decreases methylation | EXP | | 6480464 | Benzo(a)pyrene results in decreased methylation of DYNLT1 3' UTR | CTD | PMID:27901495 | bisphenol A | increases expression | ISO | RGD:620261 | 6480464 | bisphenol A results in increased expression of DYNLT1 mRNA | CTD | PMID:25181051 | bisphenol A | multiple interactions | EXP | | 6480464 | [Phenolsulfonphthalein deficiency co-treated with bisphenol A deficiency] results in increased expression of DYNLT1 protein | CTD | PMID:31629898 | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of DYNLT1 mRNA | CTD | PMID:29275510 | bisphenol A | increases methylation | ISO | RGD:620261 | 6480464 | bisphenol A results in increased methylation of DYNLT1 gene | CTD | PMID:28505145 | chlordecone | multiple interactions | ISO | RGD:732245 | 6480464 | Chlordecone inhibits the reaction [Biomarkers metabolite binds to DYNLT1B gene], Chlordecone promotes the reaction [Biomarkers metabolite binds to DYNLT1B gene] | CTD | PMID:31084621 | choline | multiple interactions | ISO | RGD:732245 | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of DYNLT1 mRNA | CTD | PMID:20938992 | chromium(6+) | decreases expression | EXP | | 6480464 | chromium hexavalent ion results in decreased expression of DYNLT1 mRNA | CTD | PMID:30690063 | cisplatin | increases expression | EXP | | 6480464 | Cisplatin results in increased expression of DYNLT1 mRNA | CTD | PMID:27594783 | clobetasol | increases expression | ISO | RGD:732245 | 6480464 | Clobetasol results in increased expression of DYNLT1B mRNA | CTD | PMID:27462272 | cobalt dichloride | decreases expression | EXP | | 6480464 | cobaltous chloride results in decreased expression of DYNLT1 mRNA | CTD | PMID:19320972 | copper(II) sulfate | decreases expression | EXP | | 6480464 | Copper Sulfate results in decreased expression of DYNLT1 mRNA | CTD | PMID:19549813 | doxorubicin | decreases expression | EXP | | 6480464 | Doxorubicin results in decreased expression of DYNLT1 mRNA | CTD | PMID:29803840 | fipronil | increases expression | ISO | RGD:620261 | 6480464 | fipronil results in increased expression of DYNLT1 mRNA | CTD | PMID:31881178 | flutamide | increases expression | ISO | RGD:620261 | 6480464 | Flutamide results in increased expression of DYNLT1 mRNA | CTD | PMID:24136188 | folic acid | multiple interactions | ISO | RGD:732245 | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of DYNLT1 mRNA | CTD | PMID:20938992 | furan | increases expression | ISO | RGD:620261 | 6480464 | furan results in increased expression of DYNLT1 mRNA | CTD | PMID:25539665 | gentamycin | increases expression | ISO | RGD:620261 | 6480464 | Gentamicins results in increased expression of DYNLT1 mRNA | CTD | PMID:22061828 | glafenine | increases expression | ISO | RGD:620261 | 6480464 | Glafenine results in increased expression of DYNLT1 mRNA | CTD | PMID:24136188 | ivermectin | decreases expression | EXP | | 6480464 | Ivermectin results in decreased expression of DYNLT1 protein | CTD | PMID:32959892 | L-methionine | multiple interactions | ISO | RGD:732245 | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of DYNLT1 mRNA | CTD | PMID:20938992 | miconazole | increases expression | ISO | RGD:732245 | 6480464 | Miconazole results in increased expression of DYNLT1B mRNA | CTD | PMID:27462272 | N-nitrosodiethylamine | multiple interactions | ISO | RGD:732245 | 6480464 | MET protein inhibits the reaction [Diethylnitrosamine results in increased expression of DYNLT1 mRNA] | CTD | PMID:17942915 | N-nitrosodiethylamine | multiple interactions | ISO | RGD:620261 | 6480464 | [Diethylnitrosamine co-treated with Thioacetamide] results in increased expression of TCTEX1 mRNA | CTD | PMID:28943392 | N-nitrosodiethylamine | increases expression | ISO | RGD:732245 | 6480464 | Diethylnitrosamine results in increased expression of DYNLT1 mRNA | CTD | PMID:17942915 | paracetamol | increases expression | EXP | | 6480464 | Acetaminophen results in increased expression of DYNLT1 mRNA | CTD | PMID:22230336 | paracetamol | increases expression | ISO | RGD:620261 | 6480464 | Acetaminophen results in increased expression of DYNLT1 mRNA | CTD | PMID:33387578 | paracetamol | affects expression | ISO | RGD:732245 | 6480464 | Acetaminophen affects the expression of DYNLT1 mRNA | CTD | PMID:17562736 | paraquat | increases expression | ISO | RGD:620261 | 6480464 | Paraquat results in increased expression of DYNLT1 mRNA | CTD | PMID:32680482 | phenol red | multiple interactions | EXP | | 6480464 | [Phenolsulfonphthalein deficiency co-treated with bisphenol A deficiency] results in increased expression of DYNLT1 protein | CTD | PMID:31629898 | pirinixic acid | increases expression | ISO | RGD:620261 | 6480464 | pirinixic acid results in increased expression of DYNLT1 mRNA | CTD | PMID:19162173 | potassium chromate | multiple interactions | EXP | | 6480464 | [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of DYNLT1 mRNA | CTD | PMID:22079256 | potassium chromate | decreases expression | EXP | | 6480464 | potassium chromate(VI) results in decreased expression of DYNLT1 mRNA | CTD | PMID:22079256, PMID:22714537 | sodium arsenite | affects expression | EXP | | 6480464 | sodium arsenite affects the expression of DYNLT1 mRNA | CTD | PMID:29319823 | sodium dichromate | increases expression | ISO | RGD:620261 | 6480464 | sodium bichromate results in increased expression of DYNLT1 mRNA | CTD | PMID:25993096 | sunitinib | decreases expression | EXP | | 6480464 | Sunitinib results in decreased expression of DYNLT1 mRNA | CTD | PMID:31533062 | tetrachloromethane | increases expression | ISO | RGD:620261 | 6480464 | Carbon Tetrachloride results in increased expression of DYNLT1 mRNA | CTD | PMID:31150632 | tetrachloromethane | multiple interactions | ISO | RGD:620261 | 6480464 | schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of DYNLT1 mRNA] | CTD | PMID:31150632 | thioacetamide | increases expression | ISO | RGD:620261 | 6480464 | Thioacetamide results in increased expression of DYNLT1 mRNA | CTD | PMID:23411599, PMID:34492290 | thioacetamide | multiple interactions | ISO | RGD:620261 | 6480464 | [Diethylnitrosamine co-treated with Thioacetamide] results in increased expression of TCTEX1 mRNA | CTD | PMID:28943392 | tungsten | increases expression | ISO | RGD:732245 | 6480464 | Tungsten results in increased expression of DYNLT1B mRNA | CTD | PMID:30912803 | vinclozolin | decreases expression | ISO | RGD:620261 | 6480464 | vinclozolin results in decreased expression of DYNLT1 mRNA | CTD | PMID:23555832 | |